Safety Analysis of Five Randomized Controlled Studies of Daratumumab in Patients With Multiple Myeloma
Samer Al Hadidi, Courtney N. Miller-Chism, Rammurti T. Kamble, Martha P. Mims
Topics & Concepts
DaratumumabMedicineInternal medicineNeutropeniaDiscontinuationAdverse effectMultiple myelomaSurgeryToxicityBortezomibMultiple Myeloma Research and TreatmentsViral-associated cancers and disordersCancer Immunotherapy and Biomarkers